# A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma

> **NCT05370144** · NA · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 42 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** Hypofractionated radiotherapy

## Key facts

- **NCT ID:** NCT05370144
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-08
- **Primary completion:** 2027-02-03
- **Final completion:** 2028-02-03
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05370144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05370144, "A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05370144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*